Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Long-term safety and efficacy of 50 mg of etanercept twice weekly in patients with psoriasis.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Long-term safety and efficacy of 50 mg of etanercept twice weekly in patients with psoriasis.
Long-term safety and efficacy of 50 mg of etanercept twice weekly in patients with psoriasis. Arch Dermatol. 2007 Jun; 143(6):719-26.
View in:
PubMed
subject areas
Anti-Inflammatory Agents, Non-Steroidal
Canada
Double-Blind Method
Drug Administration Schedule
Etanercept
Female
Humans
Immunoglobulin G
Injections, Subcutaneous
Male
Middle Aged
Psoriasis
Receptors, Tumor Necrosis Factor
Recombinant Fusion Proteins
Severity of Illness Index
Treatment Outcome
Tumor Necrosis Factor-alpha
United States
authors with profiles
Kenneth Gordon